Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Request a Protocol
Ask a
question
Favorite
This randomized phase II trial was conducted at 10 centers in the United States and Canada. Patients were stratified by clinical T stage (T2 v T3-4a); using the treatment allocation scheme described by Zelen,15 patients were randomly assigned in a 1:1 ratio to FCT or GD as the chemoradiation component of a selective bladder preservation regimen. Treatment was not blinded.
Copyright and License information: ©2018 by American Society of Clinical Oncology
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
